‘Wrong Type Of Expert’ Advised FTC On Phillip’s Colon Health Claims – CRN

FTC’s request that Bayer support claims for Phillip’s Colon Health probiotic supplement with RCTs would set a precedent that would invalidate most structure/function claims, CRN argues, saying FTC’s interpretation of competent and reliable evidence for structure/function claims disregards a wealth of scientific data.

The Federal Trade Commission request that Bayer HealthCare LLC support claims for Phillip’s Colon Health probiotic supplement with randomized, placebo-controlled trials rests on advice from “the wrong type of expert,” the Council for Responsible Nutrition argues.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America